Fenggen Fu

Title: Innovations of Fenggen Fu in Interleukin-2 Research

Introduction

Fenggen Fu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic proteins. His work focuses on enhancing the efficacy of interleukin-2, a crucial cytokine in immune response.

Latest Patents

Fenggen Fu holds a patent for a novel interleukin-2 (IL-2) mutant protein and its applications. This invention relates to an IL-2 mutant protein that exhibits reduced binding ability to the IL-2Rα receptor and increased binding ability to the IL-2Rβ receptor compared to the wild-type IL-2. The patent also encompasses a fusion protein, an immunoconjugate containing the IL-2 mutant protein, and methods for preparing this protein. Additionally, it includes a pharmaceutical composition featuring the IL-2 mutant protein and its therapeutic uses.

Career Highlights

Fenggen Fu is associated with Innovent Biologics (Suzhou) Co., Ltd., where he continues to advance his research in immunology and therapeutic protein development. His innovative approach has positioned him as a key figure in the biotechnology sector.

Collaborations

Fenggen Fu collaborates with esteemed colleagues such as Lishan Kang and Chunyin Gu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Fenggen Fu's work in the field of interleukin-2 research exemplifies the potential of biotechnology to develop novel therapeutic solutions. His contributions are paving the way for advancements in immunotherapy and related fields.